• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • Experts on Demand
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

The Market for RNA Sequencing, 3rd Edition

$5,000.00 – $10,000.00

Clear
SKU: 23-041 Categories: Biotechnology Market Research, life sciences Tags: life science, rna, rna sequencing, sequencing Pages: 61
  • Description
  • Table of Contents
  • Latest reports

Description

The sequencing market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future.  In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas.  In recent years, the use of microarrays for RNA expression analysis has dropped greatly as RNA sequencing has risen to replace and outshine it.  Similar to quantitative reverse transcription-PCR (q-RT-PCR) which has been the gold standard, there is a need for pre-defined probes which creates one of the major weaknesses of microarrays, and RNA-seq provides a number of advantages including:

  • improved sensitivity and dynamic range
  • ability to study species without reference
  • measurement of focal changes (such as single nucleotide variants, insertions and deletions)
  • detection of different transcript isoforms, splice variants and chimeric gene fusions (including previously unidentified genes and/or transcripts)

This report, The Market for RNA Sequencing, 3rd Edition, focuses on the market for RNA sequencing products — the hardware, service of the hardware, software, and consumables including for the sequencing step itself. It discusses trends, challenges, strategies, companies, and products, and provides estimates of market share and revenue growth for the market.

Information in this report includes:

  • RNA Sequencing Market, 2022 and 2027
  • RNA Sequencing Consumables Market, 2022 and 2027
  • RNA Sequencing Equipment-Related Services Market, 2022 and 2027
  • RNA Sequencing Software Market, 2022 and 2027
  • RNA Sequencing Vendor Share
  • Products on the Market
  • Software Products
  • Innovations
  • Clinical Sequencing and Products on the Market

The competitive situation and deals are covered in respective chapters. The report was produced through a combination of primary research, secondary research, and internal databases, including SEC filings, product literature, corporate websites, conferences, journals, and trade publications.

Companies Profiled Include:

  • Illumina
  • Agilent
  • 10X Genomics
  • Oxford Nanopore
  • Thermo Fisher Scientific
  • Pacific Biosciences
  • Roche
  • Qiagen
  • Tecan
  • and Others

Table of Contents

Chapter 1: Executive Summary

  • Table 1-1: RNA Sequencing Revenues by Product Segment (Consumables, Systems/Hardware, Service, and Software), 2022 (in millions of $)
  • Figure 1-1: RNA Sequencing Revenues by Product Segment (Consumables, Systems/Hardware, Service, and Software), 2022 (percent)

Scope and Methodology

Report Structure

 

Chapter 2: Market Trends

Introduction

Trends

Clinical Diagnostics, Clinical Research Applications

Cancer – leukemia/ hematological diseases; solid tumors

Infectious diseases

Rare inherited/ genetic diseases

  • Table 2-1: Selected RNA-Seq Diagnostic/ Clinical Products and Technologies

COVID-19

Illumina’s Diverse Range of Products

Other Companies’ NGS Products and Technologies

CDC’s SPHERES Consortium

Ongoing Introductions of New Products

  • Table 2-2: RNA-Sequencing Product Introductions, October 2018- July 2023

Single-cell RNA Sequencing

Selected Products/ Technologies

  • Table 2-3: Selected RNA-Seq Products and Technologies

Software/Bioinformatics

  • Table 2-4: Selected RNA-Seq Software and Related IT Tools

Partnerships, Acquisitions, Deals in Many Areas

  • Table 2-5: RNA-Seq Collaborations, Acquisitions and Other Deals, October 2014-August 2023

 

CHAPTER 3: MARKET ANALYSIS

Market Analysis

  • Table 3-1: RNA Sequencing Revenues, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2022-2027 (in millions of dollars)
  • Figure 3-1: RNA Sequencing Revenues, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2022-2027 (in millions of dollars)
  • Table 3-2: RNA Sequencing Revenue Shares, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2022-2027 (percent)
  • Figure 3-2: RNA Sequencing Revenue Shares, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2022 (percent)
  • Figure 3-3: RNA Sequencing Revenue Shares, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2027 (percent)

Market Shares

  • Table 3-3: RNA Sequencing Market Revenue Share, by Leading Companies (Illumina, Thermo, and Other), 2022 (millions of dollars and percent)
  • Figure 3-4: RNA Sequencing Revenue Shares, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2022 (percent)
  • Table 3-4: RNA Sequencing Market Revenue Share, by Region (North America, Europe, APAC, and Rest of World), 2021 (millions of dollars and percent)
  • Figure 3-5: RNA Sequencing Market Revenue Share, by Region (North America, Europe, APAC, and Rest of World), 2021 (percent)

 

CHAPTER 4: COMPANY PROFILES

Company Profiles

10X Genomics

Agilent Technologies

Illumina

New England Biolabs

Oxford Nanopore Technologies

Pacific Biosciences (PacBio)

Standard BioTools

Takara Bio Inc.

Tecan

Thermo Fisher Scientific

    The Market for RNA Sequencing, 3rd Edition
    September 8, 2023
    The Market for Single Cell Analysis in Genomics: Next-Generation Sequencing and Other Technology, 2023-2027
    April 3, 2023
    The World Market for Liquid Biopsy, 2023
    December 29, 2022
    The Market for RNA Sequencing, 2nd Edition
    September 7, 2022

Related products

  • Placeholder image

    Immunomodulators in Cancer Therapy: Emerging Products and Markets

    $3,500.00 – $7,000.00
  • Placeholder image

    Gene Expression Profiling Markets

    $995.00 – $7,990.00
  • Placeholder image

    Biophotonics – A Strategic Assessment of Photonics Technologies for Biomedical Applications, 2nd Edition

    $995.00 – $1,990.00
  • Placeholder image

    Protein Therapeutics: Monoclonal Antibodies, Plasma Proteins, Vaccines, and Other Treatments, Global Market

    $995.00 – $1,990.00

Contact Us

  •  Email Us: Customer Service

  •  Phone (US):  703-778-3080

  •  Fax:  703-778-3081

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • How Globalization and Climate Change Impact COVID-19 and the IVD Market September 20, 2023
  • IVD Trends 2023-2028: Emerging Growth Markets in Asia, Latin America, and the Middle East September 15, 2023
  • Worldwide IVD: 8 Key Trends to Watch in $106 Billion Market September 6, 2023
  • The Wide-Reaching Potential of Artificial Intelligence in Healthcare August 28, 2023
  • IVD for Pets: A $2.7 Billion Global Market July 24, 2023

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
The Worldwide Market for In Vitro Diagnostic Tests, 16th Edition In Vitro Diagnostic (IVD) Procedure Volumes (Chemistry, Immunoassays, Hematology,...
Scroll to top